Inactivation of SARS-CoV-2 by charged particles for Future Vaccine Production Applications: A Monte Carlo study

The world is still suffering from the SARS-CoV-2 pandemic, and the number of infected people is still growing in many countries in 2022. Although great strides have been made to produce effective vaccines, efforts in this field should be accelerated, particularly due to the emergence of new variants...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafiepour, Payman, Sina, Sedigheh, Mortazavi, Seyed Mohammad Javad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142867/
https://www.ncbi.nlm.nih.gov/pubmed/35663798
http://dx.doi.org/10.1016/j.radphyschem.2022.110265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142867/
https://www.ncbi.nlm.nih.gov/pubmed/35663798
http://dx.doi.org/10.1016/j.radphyschem.2022.110265

Ejemplares similares